Gentamicins

DRUG5 trials

Conditions

Enterocolitis, NecrotizingIntracerebral HemorrhagePatients Colonized by Klebsiella Pneumoniae.Premature Birth of NewbornSubarachnoid HemorrhageTherapeutic Drug MonitoringTriple Negative Breast NeoplasmsVestibular Schwannoma

Phase 3

A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer.

Active, not recruitingRPCEC00000280

Roche Servicios S.A.Triple Negative Breast Neoplasms

Start: 2018-01-11Updated: 2026-05-25

Phase 4

Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function

WithdrawnNCT02379754

Lund UniversityVestibular Schwannoma

Start: 2015-01-31End: 2020-09-30Updated: 2020-09-11

Unknown Phase

A Randomized Controlled Trial Investigating if Antibiotic Use in the First 48 Hours of Life Adversely Impacts the Preterm Infant Microbiome

CompletedNCT02477423

University of ChicagoEnterocolitis, Necrotizing, Premature Birth of Newborn

Start: 2015-07-31End: 2019-06-30Updated: 2020-10-08

Efficacy of Intestinal Decontamination in Patients Colonized by Carbapenem-resistant Klebsiella Pneumoniae and Colistin

CompletedNCT02604849

Maimónides Biomedical Research Institute of CórdobaPatients Colonized by Klebsiella Pneumoniae.

Start: 2012-07-31End: 2015-11-30Updated: 2015-11-13

Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)

NCT04132115

Azienda Sanitaria-Universitaria Integrata di UdineIntracerebral Hemorrhage, Subarachnoid Hemorrhage, Therapeutic Drug Monitoring

Start: 2019-10-01End: 2021-10-31Target: 104Updated: 2021-07-21

Related Papers

Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant, KPC-producing Klebsiella pneumoniae.